Eosinophilic granulomatosis with polyangiitis (Churg-Strauss vasculitis) presenting as Samter's triad.
暂无分享,去创建一个
[1] M. Humbert,et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. , 2015, European journal of internal medicine.
[2] E. Nizankowska-Mogilnicka,et al. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. , 2014, The Journal of allergy and clinical immunology.
[3] A. Vaglio,et al. Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art , 2013, Allergy.
[4] L. Mouthon,et al. The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort , 2011, Medicine.
[5] D. Stevenson,et al. Aspirin-Exacerbated Respiratory Disease: Evaluation and Management , 2010, Allergy, asthma & immunology research.
[6] A. Bacciu,et al. Nasal Polyposis in Churg‐Strauss Syndrome , 2008, The Laryngoscope.
[7] R J Falk,et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.
[8] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). , 2010, Arthritis and rheumatism.
[9] G. Hughes,et al. Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg‐Strauss Syndrome , 1984, Medicine.